Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases

• Published in: Respirology (Carlton, Vic.) Vol. 27; no. 4; pp. 294 - 300
• Main Authors: Brown, Kevin K., Inoue, Yoshikazu, Flaherty, Kevin R., Martinez, Fernando J., Cottin, Vincent, Bonella, Francesco, Cerri, Stefania, Danoff, Sonye K., Jouneau, Stephane, Goeldner, Rainer‐Georg, Schmidt, Martin, Stowasser, Susanne, Schlenker‐Herceg, Rozsa, Wells, Athol U.
• Format: Journal Article
• Language: English
• Published: Chichester, UK John Wiley & Sons, Ltd 01.04.2022; Wiley Subscription Services, Inc; Wiley
• Subjects: Carbon monoxide; clinical trial; Clinical trials; death; Disease Progression; fibrosing interstitial lung disease; Fibrosis; forced vital capacity; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Life Sciences; Lung; Lung diseases; Lung Diseases, Interstitial; Mortality; Original; ORIGINAL ARTICLES; pulmonary fibrosis; pulmonary function test; Vital Capacity; clinical trial; death; pulmonary function test; fibrosing interstitial lung disease; forced vital capacity; pulmonary fibrosis

Background and objective Demographic and clinical variables, measured at baseline or over time, have been associated with mortality in subjects with progressive fibrosing interstitial lung diseases (ILDs). We used data from the INPULSIS trials in subjects with idiopathic pulmonary fibrosis (IPF) and...